Cargando…
Recovery of Alopecia Universalis with Associated Nail Dystrophy Treated with Tofacitinib: A 6-year-old Child's Case Report
An emerging treatment modality whose established efficacy in systemic inflammatory diseases is now being actively explored for cutaneous disorders: tofacitinib, an oral Janus kinase inhibitor, is one such treatment. Alopecia universalis has been reported to improve with the use of tofacitinib in var...
Autor principal: | Dube, Vineet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647707/ https://www.ncbi.nlm.nih.gov/pubmed/34934298 http://dx.doi.org/10.4103/ijt.ijt_91_21 |
Ejemplares similares
-
Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
por: Anzengruber, Florian, et al.
Publicado: (2016) -
Rare Presentation of Alopecia Universalis Congenita and Twenty-nail Dystrophy in Siblings
por: Mitra, Debdeep, et al.
Publicado: (2017) -
Remarkable Improvement of Nail Changes in Alopecia Areata Universalis with 10 Months of Treatment with Tofacitinib: A Case Report
por: Ferreira, Sineida Berbert, et al.
Publicado: (2016) -
Recovery of Resistant Alopecia Areata Treated with Tofacitinib: An 8-Year-Old Child's Case Report
por: Bhokare, Anil
Publicado: (2022) -
Tofacitinib for the Treatment of Twenty-Nail Dystrophy: A Single Case Report
por: Dube, Vineet, et al.
Publicado: (2022)